MO SB 1264
died on adjournmentSB 1264 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date. This act is identical to a provision in SB 861 (2026), SB 249 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024), substantially similar to HCS/HBs 2033, 1608, 1672, & 1854 (2026), SB 1200 (2026), and SB 75 (2025), and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024). SARAH HASKINS
Missouri · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did MO SB 1264 pass?
No. MO SB 1264 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-27): Second Read and Referred S Families, Seniors and Health Committee
What is MO SB 1264 about?
MO SB 1264 is a bill in the 2026 Regular Session titled “SB 1264 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date. This act is identical to a provision in SB 861 (2026), SB 249 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024), substantially similar to HCS/HBs 2033, 1608, 1672, & 1854 (2026), SB 1200 (2026), and SB 75 (2025), and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024). SARAH HASKINS”.
Who sponsors MO SB 1264?
Brattin, Rick is the primary sponsor of MO SB 1264.
Description
SB 1264 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date. This act is identical to a provision in SB 861 (2026), SB 249 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024), substantially similar to HCS/HBs 2033, 1608, 1672, & 1854 (2026), SB 1200 (2026), and SB 75 (2025), and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024). SARAH HASKINS
- Introduced
- —
- Latest action
- 2026-01-27 — Second Read and Referred S Families, Seniors and Health Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- Brattin, Rickprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-01-27
Second Read and Referred S Families, Seniors and Health Committee
reading-2,referral-committee
2026-01-07
S First Read
reading-1
2025-12-01
Prefiled
Versions
- 5154S.01I - IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:25:15.077812Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MO&identifier=SB 1264. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.